Meet a patient with CIC
Not an actual patient.
Meet Henry,
A 51-year-old teacher
Signs and symptoms
Abnormal stool frequency1,3
Poor stool consistency3
Straining1
Treatment goal
Find a treatment that may reduce Henry’s straining due to CIC and improve his stool frequency and consistency.
Not an actual patient.
If you have adult patients like Henry with CIC, who cycle through OTC laxatives, it's time to try something different.
Are recurring CIC symptoms frustrating your adult patients taking OTCs?
According to an online survey of 610 CIC sufferers5,*:
3.5YEARS
is the average length of time CIC sufferers reported using OTC laxatives
2.6
is the average number of OTC laxatives CIC sufferers tried before speaking to an HCP about their GI symptoms
*Data from an online survey commissioned by Ironwood Pharmaceuticals, Inc. and Allergan in 2018. 501 patients with IBS-C and 610 patients with CIC qualified for the detailed survey after meeting Rome IV criteria for IBS-C or CIC.5
BSFS, Bristol Stool Form Scale; CIC, chronic idiopathic constipation; GI, gastrointestinal; HCP, healthcare provider; IBS-C, irritable bowel syndrome; OTC, over the counter.
Please see full Prescribing Information, including Boxed Warning, or visit https://www.rxabbvie.com/pdf/linzess_pi.pdf.
US-LIN-230215
References: 1. Ford AC, Moayyedi P, Lacy BE, et al. American College of Gastroenterology monograph on the management of irritable bowel syndrome and chronic idiopathic constipation. Am J Gastroenterol. 2014;109(1):S2-S27. doi:10.1038/ajg.2014.187 2. Chang L, Chey WD, Imdad A, et al. American Gastroenterological Association-American College of Gastroenterology clinical practice guideline: pharmacological management of chronic idiopathic constipation. Gastroenterology. 2023;164(7):1086-1106. doi:10.1053/j.gastro.2023.03.214 3. Lacy BE, Pimentel M, Brenner DM, et al. ACG clinical guideline: management of irritable bowel syndrome. Am J Gastroenterol. 2021;116(1):17-44. doi:10.14309/ajg.0000000000001036 4. LINZESS [package insert]. North Chicago, IL: AbbVie Inc. 5. Data on file. AbbVie Inc.
Ironwood® and its three-leaf design are registered trademarks of Ironwood Pharmaceuticals, Inc. LINZESS® and its design are registered trademarks of Ironwood Pharmaceuticals, Inc. © 2025 AbbVie and Ironwood Pharmaceuticals, Inc. All rights reserved.
The information provided in this site is intended for U.S. healthcare professionals only. The products described on this site may have different product labeling in countries outside the United States.
US-LIN-240112
